Starting insulin treatment in type 2 diabetes

Australian Prescriber

Volumn 27, Issue 4, 2004, Pages

  Wong, Jencia ^a   Yue, Dennis ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Metformin; Sulfonylureas; Thiazolidinediones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

DRUG CHOICE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG SAFETY; DRUG USE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 3542994509     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2004.075     Document Type: Review

References (3)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. (randomised trial)
2. Yki-Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1999;130:389-96. (randomised trial)
3. Phillips P. Insulins in 2002. Aust Prescr 2002;25:29-31.